Oral semaglutide
Sold by June Health · every oral semaglutide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$187
| Medication · Semaglutide/Pyridoxine Tablets, 1mg/10mg (30 tabs), lowest dose | $187 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Semaglutide/Pyridoxine Tablets, 1mg/10mg (30 tabs), lowest dose “1 mg / 10 mg (30 tabs) $187 per month” | Per month$187 | Charged today$187 |
| Semaglutide/Pyridoxine Tablets, 24mg/10mg (30 tabs), highest dose “24 mg / 10 mg (30 tabs) $329 per month” | Per month$329 | Charged today$329 |
| Semaglutide/Pyridoxine Tablets, 3-month supply, billed once “4 mg / 10 mg (3 months) 3-month supply · billed once $584 $195/mo” | Per month$195 | Charged today$584 |
We earn nothing from this link. June Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| States | Not disclosed as of September 3, 2026 |
|---|---|
| Prescriber | Asynchronous review |
| Cancellation | “Can I cancel anytime? Cancel anytime” |
Not yet checked: pharmacy, membership and consult fee.
Recorded from tryjunehealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Text fetcher found nothing; the store renders fully in a browser with a real per-dose price ladder. IMPORTANT CONTRADICTION: the product named 'Semaglutide / Pyridoxine Tablets' is titled and sold as tablets, but its own 'Dosage & Administration' section reads 'Given as a subcutaneous injection once weekly' — the page contradicts its own product name. Because of that contradiction the form is left not-disclosed for tirzepatide's identical case; for the semaglutide product the drug is still recorded as 'oral semaglutide' per its title/name, with the contradiction flagged here. The 'Tirzepatide Tablets' page has the same drug name vs. injection-instructions contradiction. Also sold but not GLP-1-priced here: 'Semaglutide with (B12 or Glycine)' from $279/mo and 'Tirzepatide with (B12 or Glycine)' from $409/mo (seen only as card previews, not opened).
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.